Skip to main content
Annals of Medicine and Surgery logoLink to Annals of Medicine and Surgery
. 2022 Apr 5;77:103572. doi: 10.1016/j.amsu.2022.103572

Hypocalcemia as a cause of reversible heart failure: A case report and review of the literature

Dana H Baqi a,b, Shaho F Ahmed b, Hiwa O Baba b,c, Fattah H Fattah a,b, Abdulwahid M Salih a,b, Rawa M Ali b, Darko HAmin H Saed b, Fahmi H Kakamad a,b,c,
PMCID: PMC9142408  PMID: 35637983

Abstract

Introduction

In both pediatric and adult populations, hypocalcemia-induced heart failure is an extremely rare presentation. The aim of the current study is to report a case of reversible heart failure caused by severe hypocalcemia resulting from hypoparathyroidism, which was resolved by correcting the serum calcium level.

Case report

A 29-year-old female presented with orthopnea, dyspnea on mild exertion, and bilateral lower limb swelling. She had a positive Trousseau's sign. Vital signs were stable except for tachycardia. On chest auscultation, there were bilateral basal fine inspiratory crackles. She was immediately treated as a case of pulmonary edema with intravenous furosemide and oxygen therapy. Subsequent treatment for correcting the hypocalcemia was then initiated.

Discussion

Hypocalcemia has been proven to influence cardiac function, resulting in lower cardiac contractility as determined by decreased left ventricular work index, stroke index, and cardiac index. In rare circumstances, the clinical, biochemical (elevation of cardiac enzymes), electrocardiographic, and echocardiographic data may lead to an incorrect diagnosis of an acute ischemic attack.

Conclusion

Hypocalcemia as a possible factor leading to heart failure should be considered in the differential diagnosis of all individuals with congestive heart failure.

Keywords: Heart failure, Cardiomyopathy, Hypocalcemia, Prolonged QT interval, Left ventricular ejection fraction

Highlights

  • Heart failure is a common clinical condition.

  • Heart failure is the most common cardiac indication for hospitalization.

  • Hypocalcemia-induced heart failure is an extremely rare presentation.

  • This study reports a case of hypocalcemia-induced heart failure.

1. Introduction

Heart failure is a common clinical condition characterized by symptoms caused by an anatomical or functional heart abnormality that limits the ventricle's capacity to fill with or eject blood [1]. It is the most common cardiac cause of hospitalization in patients over the age of 60 years [2]. Regardless of significant improvements in therapeutic modalities, heart failure is associated with significant morbidity and mortality and creates a major burden on patients, caregivers, and healthcare systems [3]. Heart failure is becoming more common around the world, owing to an increase in incidence due to population aging, an increase in the prevalence of poorly controlled risk factors such as hypertension, diabetes, and obesity, and increased survival of patients with heart failure due to the implementation of more effective, evidence-based treatments [3].

Calcium is essential for cardiac contraction and relaxation [4]. Despite its well-established role, however, hypocalcemia-induced heart failure is an extremely rare presentation in both pediatric and adult populations [5].

The current study's goal is to report a case of reversible heart failure induced by severe hypocalcemia resulting from hypoparathyroidism, which was resolved by correcting the calcium level concentration. The report is structured in accordance with SCARE guidelines and includes a brief literature review [6].

2. Case report

Patient's information: A 29-year-old female presented with orthopnea, dyspnea on mild exertion, bilateral lower limb swelling, and chest tightness. The patient had a history of epilepsy and hypocalcemia, and she was only given anticonvulsant therapy (levetiracetam) without calcium. She had no previous surgeries, no history of medication allergies, and a negative family history.

Clinical examination: Upon admission, the patient had carpopedal spasm, and this became more obvious during blood pressure measurement (Trousseau's sign). The patient's blood pressure was 140/90 mmHg, pulse rate was 110 beats per minute, respiratory rate was 25 cycles per minute, and her temperature was 37.1 °C. General physical examination revealed puffiness of the face, elevated jugular venous pressure, and bilateral pitting edema. On auscultation of the chest and precordium, there were bilateral basal fine inspiratory crackles with S3 gallop rhythm. She was immediately treated for pulmonary edema with intravenous furosemide and oxygen therapy.

Diagnostic assessment: Electrocardiogram (ECG) showed prolongation of the QT interval and T inversion in leads V1 to V4 (Fig. 1). Echocardiogram revealed global hypokinesia with severe left ventricular dysfunction (ejection fraction 20%). Blood investigations showed normal blood counts, renal function tests, liver function tests, and thyroid function tests. She had very low serum calcium (3.31 mg/dL), elevated phosphorous (9.34 mg/dL), low serum magnesium (1.13 mg/dL) and low parathyroid hormone (PTH) levels (2.33 pg/mL).

Fig. 1.

Fig. 1

The electrocardiogram (ECG) showing prolongation of the QT interval and T inversion in leads V1 to V4.

Therapeutic interventions: The patient was admitted to hospital. Intravenous calcium gluconate infusion (990 mg per 24 hours) was administered along with alfacalcidol tablet (1 mcg, three times daily) and magnesium sulfate infusion.

Follow-up: The patient did very well, with resolution of her symptoms (shortness of breath and carpopedal spasm) within three days. She was discharged on calcium carbonate, alfacalcidol, bisoprolol, spironolactone, perindopril, and indapamide. After one month from the discharge, her echocardiography showed improvement in the left ventricular function with an ejection fraction of 40% and a normal serum calcium level (8.5 mg/dL).

3. Discussion

Primary hypoparathyroidism (PHPT) is defined by an abnormally low amount of PTH release [7]. The primary function of PTH is to keep the calcium concentration in extracellular fluid (ECF) within a narrow normal range [8]. Hypocalcemia can therefore result from PTH deficiency [7]. Hypocalcemia, along with hypokalemia and hypomagnesemia, is a significant component in stress-induced cardiac cytotoxicity [9]. In the literature, a few cases of heart failure induced by hypocalcemia accompanied by hypoparathyroidism have been reported [10].

Calcium is essential for excitation–contraction coupling in the myocardium. Because the calcium confined within the sarcoplasmic reticulum is inadequate to begin contraction, extracellular calcium influx is primarily responsible for the initiation and extent of cardiac contraction [11]. These findings establish biologic plausibility and provide an approach to understanding the pathophysiologic relationship between extracellular hypocalcemia, namely low blood calcium levels, and reversible heart failure [11]. Hypocalcemia has been proven to influence cardiac function, resulting in lower cardiac contractility as determined by decreased left ventricular work index, stroke index, and cardiac index [12]. The prevalence of heart failure increases with age, rising from 1.9% in males and 1.4% in females between the ages of 40 and 59 to 14.7% and 12.8%, respectively, beyond the age of 80 [10]. The exact cause of the increased prevalence is unclear. Many risk factors for heart failure, such as diabetes and hypertension, are more common in the aged population and have been discussed elsewhere [10]. The current case was 29-year-old with no history of diabetes mellites or hypertension.

In pediatric population, vitamin D deficiency is a common cause of hypocalcemia, whereas in adults, cardiac function impairment is more often multifactorial and is typically associated with either hypoparathyroidism or chronic kidney disease while it is less likely to be associated with vitamin D deficiency alone [5]. The hypocalcemia of the presenting case was caused by low PTH. Following thyroidectomy, hypocalcemia can be induced by the unintentional removal of one or more parathyroid glands, ischemia caused by disruption of their fragile blood supply, or by merely manipulating the glands. Hypocalcemia is now recognized as a somewhat common surgical consequence that is usually temporary and asymptomatic [13].

Severe manifestations of hypocalcemia include confusion, muscle spasms, numbness in the hands, feet, and face, depression, hallucinations, muscle cramps, brittle nails, and an increased risk of bone fractures [11]. Tingling is a common sign of hypocalcemia. The Chvostek and Trousseau's signs are associated with severe hypocalcemia or a sudden onset of hypocalcemia [14]. Trousseau's sign was positive in the current case. The occurrence of hypocalcaemic heart failure as the initial manifestation of primary hypoparathyroidism is an exceedingly rare condition [15]. This was the case in this study. Hypocalcemia has been associated with a prolonged QT interval, arrhythmias, and reduced left ventricular ejection fraction (LVEF) [16]. Hypocalcemia should be evaluated in individuals with heart failure and prolonged QT intervals. Myocardial dysfunction occurs in both chronic and acute hypocalcemia and has been reported in individuals ranging in age from infancy to old age [17]. The ECG of the current case showed a prolonged QT interval with T wave inversion.

In rare circumstances, the clinical, biochemical (elevation of cardiac enzymes), electrocardiographic, and echocardiographic data may lead to an incorrect diagnosis of an acute ischemic attack [18]. Heart failure of unknown cause and abrupt onset in a young patient offers a wide range of possible diagnoses. The most common cause is myocarditis, although drugs, drug abuse, and other hazardous factors should be thoroughly investigated, with a long list of compounds implicated [19]. Among the many causes of heart failure, hypocalcemia should not be ignored, and serum calcium should always be evaluated while examining plasma electrolytes, particularly in elderly patients on loop diuretics as these can cause calcium loss in the urine [10].

Hypocalcemia-induced heart failure is resistant to diuretics and digitalis [8]. Surprisingly, once serum calcium concentration is normalized, cardiac function and pulmonary artery pressure are completely restored to normal [20]. In almost all cases of hypocalcemic-induced heart failure, reversibility is a significant component of the cardiac dysfunction, including reversal of QT prolongation and restoration of left ventricular systolic function [11]. Cardiac function may take up to 6 months to return to normal [19]. Mikhael et al. reported a case where LVEF more than doubled in a seven-day period [21]. However, in rare situations, sustained severe hypocalcemia can cause structural damage and irreversibility, as in the case of Altunbash et al. [22]. The pulmonary edema of the current case was treated with intravenous furosemide and oxygen. The hypocalcemia was treated with intravenous calcium gluconate infusion, alfacalcidol tablets, and magnesium sulfate infusion. Correction of serum calcium level was insufficient to restore myocardial function. It is believed that restoring intracellular calcium levels is more crucial than restoring myocardial function. Normalization of tissue calcium levels might take many months [14].

In conclusion, hypocalcemia as a possible cause of heart failure should be considered in the differential diagnosis of all individuals with congestive heart failure. The correction of serum calcium level results in the improvement of heart function and electrical activity.

Sources of funding

None is found.

Author contributions

Abdulwahid M. Salh: major contribution of the idea, literature review, final approval of the manuscript. Dana H. Baqi, Shaho F. Ahmed: physicians managing the case, final approval of the manuscript. Fahmi H. Kakamad, Marwan N. Hassan: Writing the manuscript, literature review, final approval of the manuscript. Rawa M. Ali, Darko H.Amin H.Saed, Hiwa O. Baba, Fattah H. Fattah: literature review, final approval of the manuscript.

Research registration unique identifying number (UIN)

Not applicable.

Guarantor

Fahmi Hussein Kakamad.

Fahmi.hussein@univsul.edu.iq.

Consent

Written informed consent was obtained from the patient's family for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Provenance and peer review

Not commissioned, externally peer-reviewed.

Declaration of competing interest

None to be declared.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.amsu.2022.103572.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.doc (56KB, doc)

References

  • 1.Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Jr., Drazner M.H., et al. ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–1852. doi: 10.1161/CIR.0b013e31829e8807. 2013. [DOI] [PubMed] [Google Scholar]
  • 2.Braunwald E. Heart Failure. JACC:Heart. Failure. 2013;1(1):1–10. doi: 10.1016/j.jchf.2012.10.002. [DOI] [PubMed] [Google Scholar]
  • 3.Zannad F. Rising incidence of heart failure demands action. Lancet. 2018;391(10120):518–519. doi: 10.1016/S0140-6736(17)32873-8. [DOI] [PubMed] [Google Scholar]
  • 4.Miura S., Yoshihisa A., Takiguchi M., Shimizu T., Nakamura Y., Yamauchi H., et al. Association of hypocalcemia with mortality in hospitalized patients with heart failure and chronic kidney disease. J. Card. Fail. 2015;21(8):621–627. doi: 10.1016/j.cardfail.2015.04.015. [DOI] [PubMed] [Google Scholar]
  • 5.Kazmi A.S., Wall B.M. Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism. Am. J. Med. Sci. 2007;333(4):226–229. doi: 10.1097/MAJ.0b013e318039b9c6. [DOI] [PubMed] [Google Scholar]
  • 6.Agha R.A., Franchi T., Sohrabi C., Mathew G., Kerwan A., Thoma A., et al. The SCARE 2020 guideline: updating consensus surgical Case Report (SCARE) guidelines. Int. J. Surg. 2020;84:226–230. doi: 10.1016/j.ijsu.2020.10.034. [DOI] [PubMed] [Google Scholar]
  • 7.Carpenter T.O. The expanding family of hypophosphatemic syndromes. J. Bone Miner. Metabol. 2012;30(1):1–9. doi: 10.1007/s00774-011-0340-2. [DOI] [PubMed] [Google Scholar]
  • 8.Saini N., Mishra S., Banerjee S., Rajput R. Hypocalcemic cardiomyopathy: a rare presenting manifestation of hypoparathyroidism. BMJ Case. Rep. CP. 2019;12(9) doi: 10.1136/bcr-2019-229822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Borkowski B.J., Cheema Y., Shahbaz A.U., Bhattacharya S.K., Weber K.T. Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited. Eur. Heart J. 2011;32(15):1846–1853. doi: 10.1093/eurheartj/ehr063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Catalano A., Basile G., Lasco A. Hypocalcemia: a sometimes overlooked cause of heart failure in the elderly. Aging Clin. Exp. Res. 2012;24(4):400–403. doi: 10.1007/BF03325272. [DOI] [PubMed] [Google Scholar]
  • 11.Newman D.B., Fidahussein S.S., Kashiwagi D.T., Kennel K.A., Kashani K.B., Wang Z., et al. Reversible cardiac dysfunction associated with hypocalcemia: a systematic review and meta-analysis of individual patient data. Heart Fail. Rev. 2014;19(2):199–205. doi: 10.1007/s10741-013-9371-1. [DOI] [PubMed] [Google Scholar]
  • 12.Hurley K., Baggs D. Hypocalcemic cardiac failure in the emergency department. J. Emerg. Med. 2005;28(2):155–159. doi: 10.1016/j.jemermed.2004.06.014. [DOI] [PubMed] [Google Scholar]
  • 13.Rangel I., Barbosa G., de Sousa C., Almeida P.B., Campelo M., Pinho T., et al. Hypocalcemia as a reversible cause of heart failure. Rev. Port. Cardiol. 2012;31(1):39–41. doi: 10.1016/j.repc.2011.09.016. [DOI] [PubMed] [Google Scholar]
  • 14.Sung J.K., Kim J.Y., Ryu D.W., Lee J.W., Youn Y.J., Yoo B.S., et al. A case of hypocalcemia-induced dilated cardiomyopathy. J. Cardio. Ultrasound. 2010;18(1):25–27. doi: 10.4250/jcu.2010.18.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Velayuthan S., Gungor N., McVie R. Hypocalcemic cardiomyopathy as initial presentation of primary hypoparathyroidism. Pediatr. Int. 2014;56(4):e23–e25. doi: 10.1111/ped.12378. [DOI] [PubMed] [Google Scholar]
  • 16.Farolfi A., Ferrario C., Aquilina M., Cecconetto L., Tartaglia A., Ibrahim T., et al. Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: a case report and literature review. Oncol. Lett. 2015;10(2):773–777. doi: 10.3892/ol.2015.3326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mavroudis K., Aloumanis K., Stamatis P., Antonakoudis G., Kifnidis K., Antonakoudis C. Irreversible end‐stage heart failure in a young patient due to severe chronic hypocalcemia associated with primary hypoparathyroidism and celiac disease. Clin. Cardiol. 2010;33(2):E72–E75. doi: 10.1002/clc.20512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rallidis L.S., Gregoropoulos P.P., Papasteriadis E.G. A case of severe hypocalcaemia mimicking myocardial infarction. Int. J. Cardiol. 1997;61(1):89–91. doi: 10.1016/s0167-5273(97)00124-1. [DOI] [PubMed] [Google Scholar]
  • 19.Çakërri L., Husi G., Minxuri D., Roko E., Vyshka G. Primary hypoparathyroidism presenting with heart failure and ventricular fibrillation. Oxford. Medical. Case. Rep. 2014;2014(4):77–79. doi: 10.1093/omcr/omu030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Solzbach U., Kitterer H.R., Haas H. Reversible congestive heart failure in severe hypocalcemia. Herz. 2010;35(7):507–511. doi: 10.1007/s00059-010-3374-7. [DOI] [PubMed] [Google Scholar]
  • 21.Mikhail N., El‐Bialy A., Grosser J. Severe hypocalcemia: a rare cause of reversible heart failure. Congest. Heart Fail. 2001;7(5):256–263. doi: 10.1111/j.1527-5299.2001.00278.x. [DOI] [PubMed] [Google Scholar]
  • 22.Altunbaş H., Balcı M.K., Yazıcıoğlu G., Semiz E., Özbilim G., Karayalçın Ü. Hypocalcemic cardiomyopathy due to untreated hypoparathyroidism. Hormone. Res. Paediatric. 2003;59(4):201–204. doi: 10.1159/000069324. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.doc (56KB, doc)

Articles from Annals of Medicine and Surgery are provided here courtesy of Wolters Kluwer Health

RESOURCES